GlassScriptPhysician profile
Kenneth Norman Sawyer
NPI 1477588614
$2,308.79
in general payments reported to CMS, 2019-2025
19 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $312 · 2021: $362 · 2022: $251 · 2023: $547 · 2024: $377 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.60 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $567.36 | 2019-2024 | Wavelight Ex500 Excimer Laser |
| Bausch & Lomb Americas INC. | $535.73 | 2022-2024 | Miebo, Vyzulta, Xipere |
| Allergan, INC. | $214.86 | 2019-2022 | |
| Biotissue Holdings INC. | $164.90 | 2023-2025 | |
| Rxsight INC | $144.16 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $138.49 | 2020 | |
| Abbvie INC. | $128.46 | 2023-2024 | Durysta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $64.03 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $57.58 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $49.37 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $47.27 | 2025 | Tyrvaya |
| Harrow Eye, LLC | $38.83 | 2024-2025 | Vevye |
| Carl Zeiss Meditec, INC. | $30.91 | 2019 | |
| Astellas Pharma US INC | $25.80 | 2023 | |
| Novartis Pharmaceuticals Corporation | $25.66 | 2019-2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $25.29 | 2019 | |
| Amgen INC. | $20.18 | 2024 | Tepezza |
| Shire North American Group INC | $16.12 | 2019 | |
| Tearlab Corp | $13.79 | 2024 | Scoutpro Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Sawyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.